GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
Health News is provided as a service to Carrington Drug site users by HealthDay. Carrington Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.